LOCALLY ADVANCED LUNG CARCINOMA
Clinical trials for LOCALLY ADVANCED LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common heartburn drug shield lung cancer patients from radiation side effects?
Symptom relief Recruiting nowThis phase II trial tests whether esomeprazole, a common acid-reducing drug, can lower the chance of severe esophagitis (inflammation of the food pipe) in people with stage III non-small cell lung cancer receiving radiation therapy. Participants take 40 mg of esomeprazole daily d…
Matched conditions: LOCALLY ADVANCED LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a simple blood test predict who responds to immunotherapy?
Knowledge-focused Recruiting nowThis study from Mayo Clinic is looking at how T cells (a type of immune cell) change during anti-PD-1 immunotherapy in people with advanced melanoma, lung cancer, or other solid tumors. Researchers will collect blood and tissue samples from 500 participants to measure specific ma…
Matched conditions: LOCALLY ADVANCED LUNG CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC